Articles from Biome Analytics

Biome Analytics has launched the Heart Failure Performance Module, a new addition to its Foundations Reporting platform. This tool is designed to help healthcare professionals improve heart failure care, patient outcomes, and operational efficiency using advanced analytics and AI-driven insights.

With a steadfast commitment to enhancing patient-centered care, Barnes-Jewish Hospital (BJH) has partnered with Biome Analytics to achieve groundbreaking improvements in reducing Acute Kidney Injury (AKI) rates among cardiovascular patients. This collaboration highlights BJH’s dedication to delivering the highest quality care through data-driven innovation and advanced clinical strategies, resulting in better outcomes and enhanced safety for hundreds of patients annually.

Biome Analytics, a leader in data-driven performance management solutions, is proud to announce the launch of its new Stroke Analytics Module, purposely built to enhance stroke care through actionable intelligence.

The global electrophysiology devices market, valued at USD 10.07 billion in 2023, is projected to expand at an impressive CAGR of 15.1% from 2024 to 2030, underscoring the increasing demand for advanced insights in this field (Grand View Research, 2023).

Biome Analytics, the leading cardiovascular performance management company, announced today that Brian Maher, MPH, has been appointed as the new Vice President of Business Development.

Biome Analytics, the leader in cardiovascular performance improvement solutions, is pleased to announce the launch of its latest innovation, the Biome Risk Audit. Developed to address challenges in risk reporting and documentation accuracy in cardiovascular care, this artificial intelligence (AI) enabled tool integrates traditionally siloed quality data and billing information to improve publicly reported outcomes and maximize revenue opportunities.

Biome Analytics, a leading innovator in cardiovascular performance improvement, is excited to announce the immediate availability of the Biome Surveillance Manager™, its advanced Cardiac Ultrasound Management tool. This innovative solution leverages advanced and proprietary machine learning methods that extend the value of the Biome Performance Network Platform by helping clients access underserved patients and grow their Cardiovascular (CV) programs.

Clinical performance management company, Biome Analytics, has announced the successful completion of SOC 2 Type 2 certification. This achievement demonstrates the company's unwavering commitment to privacy and the protection of client clinical and financial data.

Biome Analytics is pleased to announce the promotions of Matthew Esham and Amber Pawlikowski and the addition of Elsa Mersereau to its management team. These highly experienced healthcare professionals will bring a wealth of expertise and passion to the company, strengthening its commitment to excellence.

Stroke is a leading cause of death and disability worldwide, with a significant impact on patients, families, and healthcare systems. In the United States, stroke accounts for one out of every twenty deaths, and its related costs are projected to reach $240 billion by 2030. To address these challenges, Biome Analytics, a performance improvement solutions company, has recently developed a new solution - the Biome Neurovascular Solution.

Biome Analytics, a leading performance improvement company, is proud to announce its collaboration with researchers at UCSF and Cedars Sinai on an innovative study published in the American Heart Association's journal, Circulation: Cardiovascular Quality and Outcomes.

Biome Analytics, the leading cardiovascular performance management company, announced they have named Stephen Hiscott as Chief Growth Officer.

Biome Analytics, the leader in clinical performance solutions, is pleased to announce the release of the Biome Performance Manager™. This next-generation application leverages novel machine learning methods and the most advanced library of performance measures to help hospitals and care teams accelerate clinical and financial improvement and manage more improvement initiatives with fewer resources.

Biome Analytics, the leading cardiovascular performance company, is pleased to introduce the Biome Opportunity Engine™. This groundbreaking solution enables cardiovascular service lines, at individual hospitals and health systems, to prioritize hundreds of improvement initiatives to lower cost, accelerate financial performance, and improve care.